HealthEquity, Inc.
NASDAQ:HQY
86.95 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 999.587 | 861.748 | 756.556 | 733.57 | 531.993 | 287.243 | 229.525 | 178.37 | 126.786 | 87.855 | 62.015 | 46.088 |
| Cost of Revenue
| 469.713 | 371.657 | 332.85 | 318.236 | 206.084 | 106.05 | 94.609 | 72.015 | 54.188 | 39.882 | 29.213 | 21.968 |
| Gross Profit
| 529.874 | 490.091 | 423.706 | 415.334 | 325.909 | 181.193 | 134.916 | 106.355 | 72.598 | 47.973 | 32.802 | 24.12 |
| Gross Profit Ratio
| 0.53 | 0.569 | 0.56 | 0.566 | 0.613 | 0.631 | 0.588 | 0.596 | 0.573 | 0.546 | 0.529 | 0.523 |
| Reseach & Development Expenses
| 218.811 | 193.375 | 157.364 | 124.809 | 77.576 | 35.057 | 27.385 | 22.375 | 16.832 | 10.501 | 7.142 | 4.229 |
| General & Administrative Expenses
| 103.656 | 95.628 | 84.379 | 84.493 | 60.561 | 33.039 | 25.111 | 20.151 | 14.113 | 8.343 | 3.897 | 3.367 |
| Selling & Marketing Expenses
| 79.273 | 68.849 | 58.605 | 49.964 | 43.951 | 29.498 | 23.139 | 18.32 | 13.302 | 10.619 | 8.602 | 7.795 |
| SG&A
| 182.929 | 164.477 | 142.984 | 134.457 | 104.512 | 62.537 | 48.25 | 38.471 | 27.415 | 18.962 | 12.499 | 11.162 |
| Other Expenses
| 0.658 | 94.586 | 82.791 | 76.064 | 34.704 | -1.852 | -2.229 | -1.092 | -0.589 | -0.374 | -0.129 | -0.147 |
| Operating Expenses
| 401.74 | 452.438 | 383.139 | 335.33 | 216.792 | 103.523 | 80.498 | 65.143 | 46.455 | 31.1 | 21.278 | 17.028 |
| Operating Income
| 128.134 | 38.924 | 34.636 | 83.278 | 77.006 | 77.67 | 54.418 | 41.212 | 26.143 | 16.873 | 11.524 | 7.092 |
| Operating Income Ratio
| 0.128 | 0.045 | 0.046 | 0.114 | 0.145 | 0.27 | 0.237 | 0.231 | 0.206 | 0.192 | 0.186 | 0.154 |
| Total Other Income Expenses Net
| -53.094 | -77.02 | -101.377 | -79.138 | -33.851 | -1.852 | -2.229 | -1.092 | -0.589 | -1.109 | -6.106 | -0.264 |
| Income Before Tax
| 75.04 | -38.096 | -66.741 | 4.14 | 43.155 | 75.818 | 52.189 | 40.12 | 25.554 | 15.764 | 5.374 | 6.502 |
| Income Before Tax Ratio
| 0.075 | -0.044 | -0.088 | 0.006 | 0.081 | 0.264 | 0.227 | 0.225 | 0.202 | 0.179 | 0.087 | 0.141 |
| Income Tax Expense
| 19.328 | -11.953 | -22.452 | -4.694 | 3.491 | 1.919 | 4.827 | 13.744 | 8.941 | 5.598 | 4.141 | -4.667 |
| Net Income
| 55.712 | -26.143 | -44.289 | 8.834 | 39.664 | 73.899 | 47.362 | 26.376 | 16.613 | 10.166 | 1.233 | 11.169 |
| Net Income Ratio
| 0.056 | -0.03 | -0.059 | 0.012 | 0.075 | 0.257 | 0.206 | 0.148 | 0.131 | 0.116 | 0.02 | 0.242 |
| EPS
| 0.65 | -0.31 | -0.53 | 0.12 | 0.59 | 1.2 | 0.79 | 0.45 | 0.29 | 0.39 | -1.26 | 0.51 |
| EPS Diluted
| 0.64 | -0.31 | -0.53 | 0.12 | 0.58 | 1.17 | 0.77 | 0.44 | 0.28 | 0.21 | -1.26 | 0.21 |
| EBITDA
| 281.212 | 200.125 | 171.824 | 199.182 | 155.39 | 95.855 | 70.37 | 54.398 | 34.744 | 18.136 | 15.665 | 10.31 |
| EBITDA Ratio
| 0.281 | 0.232 | 0.227 | 0.272 | 0.292 | 0.334 | 0.307 | 0.305 | 0.274 | 0.206 | 0.253 | 0.224 |